BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT, Narayanan R. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA. 1995;92:12343-12346. [PMID: 8618897 DOI: 10.1073/pnas.92.26.12343] [Cited by in Crossref: 190] [Cited by in F6Publishing: 185] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Ge Z, Li W, Wang N, Liu C, Zhu Q, Björkholm M, Gruber A, Xu D. Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase. FASEB J 2010;24:579-86. [PMID: 19762557 DOI: 10.1096/fj.09-140087] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
2 Bednarek AK, Chu Y, Slaga TJ, Aldaz CM. Telomerase and cell proliferation in mouse skin papillomas. Mol Carcinog 1997;20:329-31. [PMID: 9433476 DOI: 10.1002/(sici)1098-2744(199712)20:4<329::aid-mc1>3.0.co;2-e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
3 Sharma S, Raymond E, Soda H, Izbicka E, Davidson K, Lawrence R, Von Hoff DD. Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line. Leukemia Research 1998;22:663-70. [DOI: 10.1016/s0145-2126(97)00188-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Rithidech K, Gordon CR, Cronkite EP. Telomerase Activity in Mouse Myeloid Leukemic Cells and in Cells from Normal Hematopoietic Systems. Blood Cells, Molecules, and Diseases 2001;27:496-504. [DOI: 10.1006/bcmd.2001.0412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
5 O'Hare TH, Delany ME. Telomerase gene expression in the chicken: Telomerase RNA (TR) and reverse transcriptase (TERT) transcript profiles are tissue-specific and correlate with telomerase activity. Age (Dordr) 2005;27:257-66. [PMID: 23598659 DOI: 10.1007/s11357-005-4558-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
6 Shimada Y, Nakano M, Kanda N, Murakami-murofushi K, Kim JK, Ide T, Murofushi H. Cell Cycle-Dependent Activation of Telomerase in Naturally Synchronized Culture of a True Slime Mold,Physarum polycephalum. Biochemical and Biophysical Research Communications 1997;232:492-6. [DOI: 10.1006/bbrc.1997.6327] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
7 Chang JT, Chen YL, Yang HT, Chen CY, Cheng AJ. Differential regulation of telomerase activity by six telomerase subunits. Eur J Biochem. 2002;269:3442-3450. [PMID: 12135483 DOI: 10.1046/j.1432-1033.2002.03025.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
8 Swanberg SE, Delany ME. Differential expression of genes associated with telomere length homeostasis and oncogenesis in an avian model. Mechanisms of Ageing and Development 2005;126:1060-70. [DOI: 10.1016/j.mad.2005.03.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
9 Pizzimenti S, Briatore F, Laurora S, Toaldo C, Maggio M, De Grandi M, Meaglia L, Menegatti E, Giglioni B, Dianzani MU, Barrera G. 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. Free Radic Biol Med 2006;40:1578-91. [PMID: 16632118 DOI: 10.1016/j.freeradbiomed.2005.12.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
10 Kwak CS, Yeo EJ, Moon SC, Kim YW, Ahn HJ, Park SC. Perilla Leaf, Perilla frutescens , Induces Apoptosis and G1 Phase Arrest in Human Leukemia HL-60 Cells Through the Combinations of Death Receptor-Mediated, Mitochondrial, and Endoplasmic Reticulum Stress-Induced Pathways. Journal of Medicinal Food 2009;12:508-17. [DOI: 10.1089/jmf.2008.1103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
11 Harada K, Kurisu K, Sadatomo T, Tahara H, Tahara E, Ide T, Tahara E. Growth inhibition of human glioma cells by transfection-induced P21 and its effects on telomerase activity. J Neurooncol. 2000;47:39-46. [PMID: 10930098 DOI: 10.1023/a:1006428529637] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 De Deken X, Vilain C, Van Sande J, Dumont JE, Miot F. Decrease of Telomere Length in Thyroid Adenomas without Telomerase Activity. The Journal of Clinical Endocrinology & Metabolism 1998;83:4368-72. [DOI: 10.1210/jcem.83.12.5349] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
13 Alfonso-de Matte MY, Cheng JQ, Kruk PA. Ultraviolet Irradiation- and Dimethyl Sulfoxide-Induced Telomerase Activity in Ovarian Epithelial Cell Lines. Experimental Cell Research 2001;267:13-27. [DOI: 10.1006/excr.2001.5231] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
14 He C, Liu Z, Wu Q, Zhao J, Liu R, Liu B, Zhao T. Ratiometric Fluorescent Biosensor for Visual Discrimination of Cancer Cells with Different Telomerase Expression Levels. ACS Sens 2018;3:757-62. [DOI: 10.1021/acssensors.8b00059] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
15 Ramirez RD, Wright WE, Shay JW, Taylor RS. Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 1997;108:113-7. [PMID: 8980299 DOI: 10.1111/1523-1747.ep12285654] [Cited by in Crossref: 117] [Cited by in F6Publishing: 112] [Article Influence: 4.7] [Reference Citation Analysis]
16 Hu BT, Insel RA. Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit. Eur J Immunol 1999;29:3745-53. [DOI: 10.1002/(sici)1521-4141(199911)29:11<3745::aid-immu3745>3.0.co;2-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002;66:407-425, table of contents. [PMID: 12208997 DOI: 10.1128/mmbr.66.3.407-425.2002] [Cited by in Crossref: 549] [Cited by in F6Publishing: 225] [Article Influence: 27.5] [Reference Citation Analysis]
18 Brousset P, Al Saati T, Chaouche N, Zenou R, Schlaifer D, Chittal S, Delsol G. Telomerase Activity in Reactive and Neoplastic Lymphoid Tissues: Infrequent Detection of Activity in Hodgkin's Disease. Blood 1997;89:26-31. [DOI: 10.1182/blood.v89.1.26.26_26_31] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
19 Cerezo A, Stark HJ, Moshir S, Boukamp P. Constitutive overexpression of human telomerase reverse transcriptase but not c-myc blocks terminal differentiation in human HaCaT skin keratinocytes. J Invest Dermatol 2003;121:110-9. [PMID: 12839571 DOI: 10.1046/j.1523-1747.2003.12304.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
20 Richards LA, Kumari A, Knezevic K, Thoms JA, von Jonquieres G, Napier CE, Ali Z, O'Brien R, Marks-Bluth J, Maritz MF, Pickett HA, Morris J, Pimanda JE, MacKenzie KL. DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts. Haematologica 2020;105:1517-26. [PMID: 31413099 DOI: 10.3324/haematol.2018.215699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
21 Sun J, Huang H, Zhu Y, Lan J, Li J, Lai X, Yu J. The Expression of Telomeric Proteins and Their Probable Regulation of Telomerase during the Differentiation of All-trans-Retinoic Acid-Responsive and -Resistant Acute Promyelocytic Leukemia Cells. International Journal of Hematology 2005;82:215-23. [DOI: 10.1532/ijh97.a10420] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
22 Kleinschmidt-DeMasters BK, Shroyer AL, Hashizumi TL, Evans LC, Markham N, Kindt G, Shroyer KR. Part I. Telomerase levels in human metastatic brain tumors show four-fold logarithmic variability but no correlation with tumor type or interval to patient demise. J Neurol Sci 1998;161:116-23. [PMID: 9879692 DOI: 10.1016/s0022-510x(98)00253-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
23 Albanell J, Bosl GJ, Reuter VE, Engelhardt M, Franco S, Moore MA, Dmitrovsky E. Telomerase activity in germ cell cancers and mature teratomas. J Natl Cancer Inst 1999;91:1321-6. [PMID: 10433622 DOI: 10.1093/jnci/91.15.1321] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
24 Buchkovich KJ. Telomeres, telomerase, and the cell cycle. In: Meijer L, Guidet S, Vogel L, editors. Progress in Cell Cycle Research. Boston: Springer US; 1996. pp. 187-95. [DOI: 10.1007/978-1-4615-5873-6_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
25 Nakano M, Kakiuchi Y, Shimada Y, Ohyama M, Ogiwara Y, Sasaki-higashiyama N, Yano N, Ikeda F, Yamada E, Iwamatsu A, Kobayashi K, Nishiyama K, Ichikawa S, Kaji K, Ide T, Murofushi H, Murakami-murofushi K. MOV10 as a novel telomerase-associated protein. Biochemical and Biophysical Research Communications 2009;388:328-32. [DOI: 10.1016/j.bbrc.2009.08.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
26 Shariftabrizi A, Khorramizadeh MR, Saadat F, Alimoghadam K, Safavifar F, Ebrahimkhani MR. Concomitant reduction of matrix metalloproteinase-2 secretion and intracellular reactive oxygen species following anti-sense inhibition of telomerase activity in PC-3 prostate carcinoma cells. Mol Cell Biochem 2005;273:109-16. [PMID: 16013445 DOI: 10.1007/s11010-005-8158-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
27 Soria J, Moon C, Wang L, Hittelman WN, Jang SJ, Sun S, Lee JJ, Liu D, Kurie JM, Morice RC, Lee JS, Hong WK, Mao L. Effects of N-(4-Hydroxyphenyl)retinamide on hTERT Expression in the Bronchial Epithelium of Cigarette Smokers. JNCI Journal of the National Cancer Institute 2001;93:1257-63. [DOI: 10.1093/jnci/93.16.1257] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
28 Jacczak B, Rubiś B, Totoń E. Potential of Naturally Derived Compounds in Telomerase and Telomere Modulation in Skin Senescence and Aging. Int J Mol Sci 2021;22:6381. [PMID: 34203694 DOI: 10.3390/ijms22126381] [Reference Citation Analysis]
29 Liang L, Wang X, Xing D, Chen T, Chen WR. Noninvasive determination of cell nucleoplasmic viscosity by fluorescence correlation spectroscopy. J Biomed Opt 2009;14:024013. [PMID: 19405743 DOI: 10.1117/1.3088141] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
30 Saeed H, Iqtedar M. Stem cell function and maintenance - ends that matter: role of telomeres and telomerase. J Biosci 2013;38:641-9. [PMID: 23938394 DOI: 10.1007/s12038-013-9346-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
31 Liu J. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB j 1999;13:2091-104. [DOI: 10.1096/fasebj.13.15.2091] [Cited by in Crossref: 173] [Cited by in F6Publishing: 165] [Article Influence: 7.5] [Reference Citation Analysis]
32 Okamoto T, Aoyama T, Nakayama T, Nakamata T, Hosaka T, Nishijo K, Nakamura T, Kiyono T, Toguchida J. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochemical and Biophysical Research Communications 2002;295:354-61. [DOI: 10.1016/s0006-291x(02)00661-7] [Cited by in Crossref: 190] [Cited by in F6Publishing: 89] [Article Influence: 9.5] [Reference Citation Analysis]
33 Katakura Y, Yamamoto K, Miyake O, Yasuda T, Uehara N, Nakata E, Kawamoto S, Shirahata S. Bidirectional Regulation of Telomerase Activity in a Subline Derived from Human Lung Adenocarcinoma. Biochemical and Biophysical Research Communications 1997;237:313-7. [DOI: 10.1006/bbrc.1997.7104] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
34 Nishimura A, Nakahara T, Ueno T, Sasaki K, Yoshida S, Kyo S, Howley PM, Sakai H. Requirement of E7 oncoprotein for viability of HeLa cells. Microbes Infect 2006;8:984-93. [PMID: 16500131 DOI: 10.1016/j.micinf.2005.10.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
35 Roybon L, Christophersen NS, Brundin P, Li J. Stem cell therapy for Parkinson?s disease: where do we stand? Cell Tissue Res 2004;318:261-73. [DOI: 10.1007/s00441-004-0946-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
36 Dome JS, Look AT. Three molecular determinants of malignant conversion and their potential as therapeutic targets: . Current Opinion in Oncology 1999;11:58. [DOI: 10.1097/00001622-199901000-00013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
37 Lin Z, Lim S, Viani MA, Sapp M, Lim MS. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. Am J Pathol 2001;159:711-9. [PMID: 11485929 DOI: 10.1016/S0002-9440(10)61742-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
38 Wang Z, Ramin SA, Tsai C, Lui P, Ruckle HC, Beltz RE, Sands JF. Telomerase activity in prostate sextant needle cores from radical prostatectomy specimens. Urologic Oncology: Seminars and Original Investigations 2001;6:57-62. [DOI: 10.1016/s1078-1439(00)00102-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
39 Kruk PA, Orren DK, Bohr VA. Telomerase activity is elevated in early S phase in hamster cells. Biochem Biophys Res Commun 1997;233:717-22. [PMID: 9168921 DOI: 10.1006/bbrc.1997.6549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
40 Yan T, Ooi WF, Qamra A, Cheung A, Ma D, Sundaram GM, Xu C, Xing M, Poon L, Wang J, Loh YP, Ho JHJ, Ng JJQ, Ramlee MK, Aswad L, Rozen SG, Ghosh S, Bard FA, Sampath P, Tergaonkar V, Davies JOJ, Hughes JR, Goh E, Bi X, Fullwood MJ, Tan P, Li S. HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis. Nat Commun 2018;9:100. [PMID: 29311615 DOI: 10.1038/s41467-017-02601-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
41 Maji B, Kumar K, Kaulage M, Muniyappa K, Bhattacharya S. Design and Synthesis of New Benzimidazole–Carbazole Conjugates for the Stabilization of Human Telomeric DNA, Telomerase Inhibition, and Their Selective Action on Cancer Cells. J Med Chem 2014;57:6973-88. [DOI: 10.1021/jm500427n] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 7.8] [Reference Citation Analysis]
42 Yeung SC, Chiu AC, Vassilopoulou-Sellin R, Gagel RF. The endocrine effects of nonhormonal antineoplastic therapy. Endocr Rev 1998;19:144-72. [PMID: 9570035 DOI: 10.1210/edrv.19.2.0328] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
43 Méndez-López LF, Davila-Velderrain J, Domínguez-Hüttinger E, Enríquez-Olguín C, Martínez-García JC, Alvarez-Buylla ER. Gene regulatory network underlying the immortalization of epithelial cells. BMC Syst Biol 2017;11:24. [PMID: 28209158 DOI: 10.1186/s12918-017-0393-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
44 Shah N, Choksi T, Patel D, Vora H, Ghosh N, Trivedi T, Trivedi K. Telomerase Activity in Breast Cancer in Western India (Gujarat). Int J Biol Markers 2002;17:49-55. [DOI: 10.1177/172460080201700106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
45 Nason-burchenal K, Maerz W, Allopenna J, Martin P, Dmitrovsky E, Albanell J, Moore MA. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Differentiation 1997;61:321-31. [DOI: 10.1046/j.1432-0436.1997.6150321.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
46 Kamranvar SA, Masucci MG. Regulation of Telomere Homeostasis during Epstein-Barr virus Infection and Immortalization. Viruses 2017;9:E217. [PMID: 28792435 DOI: 10.3390/v9080217] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
47 Shay JW. Telomerase in human development and cancer. J Cell Physiol 1997;173:266-70. [PMID: 9365534 DOI: 10.1002/(SICI)1097-4652(199711)173:2<266::AID-JCP33>3.0.CO;2-B] [Cited by in Crossref: 92] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
48 Edqvist A, Rebetz J, Järås M, Rydelius A, Skagerberg G, Salford LG, Widegren B, Fan X. Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells. Molecular Therapy 2006;14:139-48. [DOI: 10.1016/j.ymthe.2005.12.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
49 Nicholls C, Li H, Wang JQ, Liu JP. Molecular regulation of telomerase activity in aging. Protein Cell 2011;2:726-38. [PMID: 21976062 DOI: 10.1007/s13238-011-1093-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
50 Rowley PT. Telomerase: putting an end to DNA. Cancer Invest 1998;16:170-4. [PMID: 9541631 DOI: 10.3109/07357909809050032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
51 Hou M, Xu D, Björkholm M, Gruber A. Real-Time Quantitative Telomeric Repeat Amplification Protocol Assay for the Detection of Telomerase Activity2. Clinical Chemistry 2001;47:519-24. [DOI: 10.1093/clinchem/47.3.519] [Cited by in Crossref: 122] [Cited by in F6Publishing: 81] [Article Influence: 5.8] [Reference Citation Analysis]
52 Zhu H, Fu W, Mattson MP. The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J Neurochem. 2000;75:117-124. [PMID: 10854254 DOI: 10.1046/j.1471-4159.2000.0750117.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 110] [Article Influence: 4.9] [Reference Citation Analysis]
53 Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichikawa T, Shay J, Yokoyama T. Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? European Journal of Cancer 1997;33:1932-6. [DOI: 10.1016/s0959-8049(97)00226-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
54 Kim TH, Kim Y, Ahn S, Kim J, Ki C, Oh YL, Kim K, Yun JW, Park W, Choe J, Kim J, Kim JS, Kim SW, Chung JH. TERT promoter mutations and long-term survival in patients with thyroid cancer. Endocrine-Related Cancer 2016;23:813-23. [DOI: 10.1530/erc-16-0219] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
55 Erlitzki R, Minuk GY. Telomeres, telomerase and HCC: the long and the short of it. J Hepatol. 1999;31:939-945. [PMID: 10580594 DOI: 10.1016/s0168-8278(99)80298-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
56 Hirose M, Abe-Hashimoto J, Ogura K, Tahara H, Ide T, Yoshimura T. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. J Cancer Res Clin Oncol 1997;123:337-44. [PMID: 9222300 DOI: 10.1007/BF01438310] [Cited by in Crossref: 68] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
57 Yang SW, Jin E, Chung IK, Kim WT. Cell cycle‐dependent regulation of telomerase activity by auxin, abscisic acid and protein phosphorylation in tobacco BY‐2 suspension culture cells. The Plant Journal 2002;29:617-26. [DOI: 10.1046/j.0960-7412.2001.01244.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
58 Yang SM, Fang DC, Yang JL, Liang GP, Lu R, Luo YH, Liu WW. Effect of antisense human telomerase RNA onmalignant phenotypes of gastric carcinoma. J Gastroenterol Hepatol. 2002;17:1144-1152. [PMID: 12453272 DOI: 10.1046/j.1440-1746.2002.02857.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
59 Holt SE, Shay JW. Role of telomerase in cellular proliferation and cancer. J Cell Physiol 1999;180:10-8. [PMID: 10362013 DOI: 10.1002/(SICI)1097-4652(199907)180:1<10::AID-JCP2>3.0.CO;2-D] [Cited by in Crossref: 145] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
60 Larrivée-Vanier S, Magne F, Patey N, Chanoine JP, Vuissoz JM, Van Vliet G, Deladoëy J. Conserved Telomere Length in Human Ectopic Thyroids: An Argument Against Premature Differentiation Causing Arrested Migration. Thyroid 2015;25:1050-4. [PMID: 26131731 DOI: 10.1089/thy.2015.0204] [Reference Citation Analysis]
61 Nozaki Y, Liu T, Hatano K, Gharaee-kermani M, Phan SH. Induction of Telomerase Activity in Fibroblasts from Bleomycin-Injured Lungs. Am J Respir Cell Mol Biol 2000;23:460-5. [DOI: 10.1165/ajrcmb.23.4.3958] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
62 Schrader M, Müller M, Schulze W, Heicappell R, Krause H, Straub B, Miller K. Quantification of telomerase activity, porphobilinogen deaminase and human telomerase reverse transcriptase mRNA in testicular tissue - new parameters for a molecular diagnostic classification of spermatogenesis disorders. Int J Androl 2002;25:34-44. [PMID: 11869375 DOI: 10.1046/j.1365-2605.2002.00321.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
63 Sharma S, Raymond E, Soda H, Sun D, Hilsenbeck S, Sharma A, Izbicka E, Windle B, Von Hoff D. Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Annals of Oncology 1997;8:1063-74. [DOI: 10.1023/a:1008206420505] [Cited by in Crossref: 36] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
64 Li H, Zhao L, Funder JW, Liu J. Protein Phosphatase 2A Inhibits Nuclear Telomerase Activity in Human Breast Cancer Cells. Journal of Biological Chemistry 1997;272:16729-32. [DOI: 10.1074/jbc.272.27.16729] [Cited by in Crossref: 131] [Cited by in F6Publishing: 125] [Article Influence: 5.2] [Reference Citation Analysis]
65 Chapman EJ, Kelly G, Knowles MA. Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells. Mol Cancer Res. 2008;6:1154-1168. [PMID: 18644980 DOI: 10.1158/1541-7786.mcr-07-2168] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
66 Zhu X, Kumar R, Mandal M, Sharma N, Sharma HW, Dhingra U, Sokoloski JA, Hsiao R, Narayanan R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci U S A 1996;93:6091-5. [PMID: 8650224 DOI: 10.1073/pnas.93.12.6091] [Cited by in Crossref: 152] [Cited by in F6Publishing: 155] [Article Influence: 5.8] [Reference Citation Analysis]
67 Lee MK, Hande MP, Sabapathy K. Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis. J Cell Sci 2005;118:819-29. [PMID: 15687103 DOI: 10.1242/jcs.01673] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
68 Pan Q, Simpson RU. c-myc intron element-binding proteins are required for 1, 25-dihydroxyvitamin D3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4. J Biol Chem 1999;274:8437-44. [PMID: 10085075 DOI: 10.1074/jbc.274.13.8437] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
69 Liu Z, Zhao J, Zhang R, Han G, Zhang C, Liu B, Zhang Z, Han M, Gao X. Cross-Platform Cancer Cell Identification Using Telomerase-Specific Spherical Nucleic Acids. ACS Nano 2018;12:3629-37. [DOI: 10.1021/acsnano.8b00743] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 9.8] [Reference Citation Analysis]
70 Shao JC, Wu JF, Wang DB, Qin R, Zhang H. Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance. World J Gastroenterol 2003; 9(3): 427-431 [PMID: 12632490 DOI: 10.3748/wjg.v9.i3.427] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
71 Boggs SS. The Hematopoietic Microenvironment: Phylogeny and Ontogeny of the Hematopoietic Microenvironment. Hematology 1999;4:31-44. [PMID: 11399551 DOI: 10.1080/10245332.1999.11746428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Bickenbach JR, Vormwald-dogan V, Bachor C, Bleuel K, Schnapp G, Boukamp P. Telomerase is Not an Epidermal Stem Cell Marker and is Downregulated by Calcium. Journal of Investigative Dermatology 1998;111:1045-52. [DOI: 10.1046/j.1523-1747.1998.00420.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 2.3] [Reference Citation Analysis]
73 Holt SE, Shay JW, Wright WE. Refining the telomere-telomerase hypothesis of aging and cancer. Nat Biotechnol. 1996;14:836-839. [PMID: 9631006 DOI: 10.1038/nbt0796-836] [Cited by in Crossref: 124] [Cited by in F6Publishing: 113] [Article Influence: 5.2] [Reference Citation Analysis]
74 Drummond MW, Balabanov S, Holyoake TL, Brummendorf TH. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells. Stem Cells 2007;25:1853-61. [PMID: 17510216 DOI: 10.1634/stemcells.2007-0057] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
75 Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc Natl Acad Sci U S A 2001;98:6662-7. [PMID: 11371621 DOI: 10.1073/pnas.111464998] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 3.0] [Reference Citation Analysis]
76 Balasubramanian S, Kim KH, Ahmad N, Mukhtar H. Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse. Oncogene. 1999;18:1297-1302. [PMID: 10022811 DOI: 10.1038/sj.onc.1202417] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
77 Maritz MF, Napier CE, Wen VW, MacKenzie KL. Targeting telomerase in hematologic malignancy. Future Oncol 2010;6:769-89. [PMID: 20465390 DOI: 10.2217/fon.10.42] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
78 Seol JG, Kim ES, Park WH, Jung CW, Kim BK, Lee YY. Telomerase activity in acute myelogenous leukaemia: clinical and biological implications. Br J Haematol. 1998;100:156-165. [PMID: 9450805 DOI: 10.1046/j.1365-2141.1998.00524.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
79 West MD. Embryonic Stem Cells: Prospects of Regenerative Medicine for the Treatment of Human Aging. In: Fahy GM, West MD, Coles LS, Harris SB, editors. The Future of Aging. Dordrecht: Springer Netherlands; 2010. pp. 451-87. [DOI: 10.1007/978-90-481-3999-6_14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
80 Perrault SD, Hornsby PJ, Betts DH. Global gene expression response to telomerase in bovine adrenocortical cells. Biochem Biophys Res Commun 2005;335:925-36. [PMID: 16105662 DOI: 10.1016/j.bbrc.2005.07.156] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
81 Liu DY, Peng ZH, Qiu GQ, Zhou CZ. Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis. World J Gastroenterol 2003; 9(8): 1859-1862 [PMID: 12918139 DOI: 10.3748/wjg.v9.i8.1859] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
82 Yamada O, Ozaki K, Nakatake M, Akiyama M, Kawauchi K, Matsuoka R. Multistep regulation of telomerase during differentiation of HL60 cells. Journal of Leukocyte Biology 2008;83:1240-8. [DOI: 10.1189/jlb.1207848] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
83 Ishii Y, Tsuyama N, Maeda S, Tahara H, Ide T. Telomerase activity in hybrids between telomerase-negative and telomerase-positive immortal human cells is repressed in the different complementation groups but not in the same complementation group of immortality. Mechanisms of Ageing and Development 1999;110:175-93. [DOI: 10.1016/s0047-6374(99)00054-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
84 Norrback K, Enblad G, Erlanson M, Sundström C, Roos G. Telomerase Activity in Hodgkin's Disease. Blood 1998;92:567-73. [DOI: 10.1182/blood.v92.2.567.414a18_567_573] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
85 Maxwell SA, Capp D, Acosta SA. Telomerase Activity in Immortalized Endothelial Cells Undergoing p53-Mediated Apoptosis. Biochemical and Biophysical Research Communications 1997;241:642-5. [DOI: 10.1006/bbrc.1997.7797] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
86 Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization. Cell 1997;90:785-95. [DOI: 10.1016/s0092-8674(00)80538-3] [Cited by in Crossref: 1215] [Cited by in F6Publishing: 434] [Article Influence: 48.6] [Reference Citation Analysis]
87 Khalyavkin AV. Phenoptosis as genetically determined aging influenced by signals from the environment. Biochemistry Moscow 2013;78:1001-5. [DOI: 10.1134/s0006297913090058] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
88 Rea MA, Rice RH. Telomerase deregulation in immortalized human epidermal cells: Modulation by cellular microenvironment. Int J Cancer 2001;94:669-73. [DOI: 10.1002/ijc.1521] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
89 Kipling D. Mammalian Telomerase: Catalytic Subunit and Knockout Mice. Human Molecular Genetics 1997;6:1999-2004. [DOI: 10.1093/hmg/6.12.1999] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
90 Yaar M, Gilchrest BA. Skin aging. Clinics in Geriatric Medicine 2001;17:617-30. [DOI: 10.1016/s0749-0690(05)70089-6] [Cited by in Crossref: 109] [Cited by in F6Publishing: 14] [Article Influence: 5.2] [Reference Citation Analysis]
91 Ramakrishnan S, Sharma HW, Farris AD, Kaufman KM, Harley JB, Collins K, Pruijn GJ, van Venrooij WJ, Martin ML, Narayanan R. Characterization of human telomerase complex. Proc Natl Acad Sci USA. 1997;94:10075-10079. [PMID: 9294165 DOI: 10.1073/pnas.94.19.10075] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
92 Lichtsteiner SP, Lebkowski JS, Vasserot AP. Telomerase. A target for anticancer therapy. Ann N Y Acad Sci. 1999;886:1-11. [PMID: 10667198 DOI: 10.1111/j.1749-6632.1999.tb09395.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
93 Klapper W, Singh KK, Heidorn K, Parwaresch R, Krupp G. Regulation of telomerase activity in quiescent immortalized human cells. Biochim Biophys Acta 1998;1442:120-6. [PMID: 9804918 DOI: 10.1016/s0167-4781(98)00155-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
94 Mergny JL, Riou JF, Mailliet P, Teulade-Fichou MP, Gilson E. Natural and pharmacological regulation of telomerase. Nucleic Acids Res 2002;30:839-65. [PMID: 11842096 DOI: 10.1093/nar/30.4.839] [Cited by in Crossref: 261] [Cited by in F6Publishing: 249] [Article Influence: 13.1] [Reference Citation Analysis]
95 Beitzinger M, Oswald C, Beinoraviciute-Kellner R, Stiewe T. Regulation of telomerase activity by the p53 family member p73. Oncogene 2006;25:813-26. [PMID: 16205639 DOI: 10.1038/sj.onc.1209125] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
96 Hung SC, Yang DM, Chang CF, Lin RJ, Wang JS, Low-Tone Ho L, Yang WK. Immortalization without neoplastic transformation of human mesenchymal stem cells by transduction with HPV16 E6/E7 genes. Int J Cancer. 2004;110:313-319. [PMID: 15095294 DOI: 10.1002/ijc.20126] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 3.5] [Reference Citation Analysis]
97 Privette Vinnedge LM, Kappes F, Nassar N, Wells SI. Stacking the DEK: from chromatin topology to cancer stem cells. Cell Cycle 2013;12:51-66. [PMID: 23255114 DOI: 10.4161/cc.23121] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
98 Bryan TM, Englezou A, Dunham MA, Reddel RR. Telomere length dynamics in telomerase-positive immortal human cell populations. Exp Cell Res 1998;239:370-8. [PMID: 9521855 DOI: 10.1006/excr.1997.3907] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 3.3] [Reference Citation Analysis]
99 Bednarek A, Shilkaitis A, Green A, Lubet R, Kelloff G, Christov K, Aldaz CM. Suppression of cell proliferation and telomerase activity in 4- (hydroxyphenyl)retinamide-treated mammary tumors. Carcinogenesis. 1999;20:879-883. [PMID: 10334206 DOI: 10.1093/carcin/20.5.879] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
100 Vietor M, Winter S, Groscurth P, Naumann U, Weller M. On the significance of telomerase activity in human malignant glioma cells. Eur J Pharmacol 2000;407:27-37. [PMID: 11050287 DOI: 10.1016/s0014-2999(00)00726-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
101 Maeda T, Kurita R, Yokoo T, Tani K, Makino N. Telomerase inhibition promotes an initial step of cell differentiation of primate embryonic stem cell. Biochemical and Biophysical Research Communications 2011;407:491-4. [DOI: 10.1016/j.bbrc.2011.03.044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
102 Fujimoto K, Takahashi M. Telomerase Activity in Human Leukemic Cell Lines Is Inhibited by Antisense Pentadecadeoxynucleotides Targeted against c-myc mRNA. Biochemical and Biophysical Research Communications 1997;241:775-81. [DOI: 10.1006/bbrc.1997.7806] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 1.6] [Reference Citation Analysis]
103 Vanneste S, Maes L, De Smet I, Himanen K, Naudts M, Inze D, Beeckman T. Auxin regulation of cell cycle and its role during lateral root initiation. Physiol Plant 2005;123:139-46. [DOI: 10.1111/j.1399-3054.2005.00466.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
104 Fitzgerald MS, McKnight TD, Shippen DE. Characterization and developmental patterns of telomerase expression in plants. Proc Natl Acad Sci U S A 1996;93:14422-7. [PMID: 8962067 DOI: 10.1073/pnas.93.25.14422] [Cited by in Crossref: 110] [Cited by in F6Publishing: 103] [Article Influence: 4.4] [Reference Citation Analysis]
105 Yamada O, Takanashi M, Ujihara M, Mizoguchi H. Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change. Leukemia Research 1998;22:711-7. [DOI: 10.1016/s0145-2126(98)00065-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
106 Shay JW, Werbin H, Wright WE. Telomerase assays in the diagnosis and prognosis of cancer. Ciba Found Symp 1997;211:148-55; discussion 155-9. [PMID: 9524756 DOI: 10.1002/9780470515433.ch10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.0] [Reference Citation Analysis]
107 Liu WH, Hsu CY, Yung BY. Nucleophosmin/B23 regulates the susceptibility of human leukemia HL-60 cells to sodium butyrate-induced apoptosis and inhibition of telomerase activity. Int J Cancer 1999;83:765-71. [DOI: 10.1002/(sici)1097-0215(19991210)83:6<765::aid-ijc12>3.0.co;2-j] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
108 Pendino F, Sahraoui T, Lanotte M, Ségal-bendirdjian E. A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation. Leukemia 2002;16:826-32. [DOI: 10.1038/sj.leu.2402470] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
109 Kim W, Shay JW. Long-range telomere regulation of gene expression: Telomere looping and telomere position effect over long distances (TPE-OLD). Differentiation. 2018;99:1-9. [PMID: 29197683 DOI: 10.1016/j.diff.2017.11.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
110 Albanell J, Engelhardt M, Han W, Moore MAS, Lonardo F, Rusch V, Langenfeld J, Klimstra D, Venkatraman E, Dmitrovsky E. High Telomerase Activity in Primary Lung Cancers: Association With Increased Cell Proliferation Rates and Advanced Pathologic Stage. JNCI Journal of the National Cancer Institute 1997;89:1609-15. [DOI: 10.1093/jnci/89.21.1609] [Cited by in Crossref: 138] [Cited by in F6Publishing: 114] [Article Influence: 5.5] [Reference Citation Analysis]
111 Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishizaka Y, Liu J, Haqqi T, Nishiyama A, Villeponteau B, Cowell JK, Barna BP. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J 1998;12:801-11. [PMID: 9657520 DOI: 10.1096/fasebj.12.10.801] [Cited by in Crossref: 123] [Cited by in F6Publishing: 113] [Article Influence: 5.1] [Reference Citation Analysis]
112 Coffman FD, Studzinski GP. Differentiation-related mechanisms which suppress DNA replication. Exp Cell Res 1999;248:58-73. [PMID: 10094813 DOI: 10.1006/excr.1999.4457] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 2.0] [Reference Citation Analysis]
113 Wu HL, Hsu CY, Liu WH, Yung BY. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int J Cancer 1999;81:923-9. [DOI: 10.1002/(sici)1097-0215(19990611)81:6<923::aid-ijc14>3.0.co;2-d] [Cited by in Crossref: 74] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
114 Matsumura T. Cellular genealogy of in-vitro senescence and immortalization. Prog Mol Subcell Biol 2000;24:103-19. [PMID: 10547860 DOI: 10.1007/978-3-662-06227-2_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol. 1996;16:2932-2939. [PMID: 8649404 DOI: 10.1128/mcb.16.6.2932] [Cited by in Crossref: 255] [Cited by in F6Publishing: 72] [Article Influence: 9.8] [Reference Citation Analysis]
116 Leber B, Bacchetti S. Telomeres and telomerase in normal and malignant haematologic cells. Leuk Lymphoma 1996;24:1-9. [PMID: 9049957 DOI: 10.3109/10428199609045709] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
117 Ahmed A, Tollefsbol T. Telomeres, Telomerase, and Telomerase Inhibition: Clinical Implications for Cancer. Journal of the American Geriatrics Society 2003;51:116-22. [DOI: 10.1034/j.1601-5215.2002.51019.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
118 Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA, Melnick SJ. Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Letters 2002;184:1-6. [DOI: 10.1016/s0304-3835(02)00192-1] [Cited by in Crossref: 89] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
119 Betts DH, King WA. Telomerase activity and telomere detection during early bovine development. Dev Genet 1999;25:397-403. [PMID: 10570471 DOI: 10.1002/(SICI)1520-6408(1999)25:4<397::AID-DVG13>3.0.CO;2-J] [Cited by in Crossref: 54] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
120 Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA. 1998;95:90-92. [PMID: 9419332 DOI: 10.1073/pnas.95.1.90] [Cited by in Crossref: 286] [Cited by in F6Publishing: 267] [Article Influence: 11.9] [Reference Citation Analysis]
121 Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, Harn HJ. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Eur J Surg Oncol. 2002;28:225-234. [PMID: 11944954 DOI: 10.1053/ejso.2001.1237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
122 Hiyama K, Hiyama E, Shay JW. Telomeres and Telomerase in Humans. In: Hiyama K, editor. Telomeres and Telomerase in Cancer. Totowa: Humana Press; 2009. pp. 3-21. [DOI: 10.1007/978-1-60327-879-9_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
123 Miura T, Katakura Y, Yamamoto K, Uehara N, Tsuchiya T, Kim EH, Shirahata S. Neural stem cells lose telomerase activity upon differentiating into astrocytes. Cytotechnology 2001;36:137-44. [PMID: 19003324 DOI: 10.1023/A:1014016315003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
124 Broccoli D, Godley LA, Donehower LA, Varmus HE, de Lange T. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol Cell Biol 1996;16:3765-72. [PMID: 8668193 DOI: 10.1128/MCB.16.7.3765] [Cited by in Crossref: 117] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
125 Rashid-Kolvear F, Taboski MA, Nguyen J, Wang DY, Harrington LA, Done SJ. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells. BMC Cancer 2010;10:390. [PMID: 20650001 DOI: 10.1186/1471-2407-10-390] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
126 Zhu Q, Liu C, Ge Z, Fang X, Zhang X, Strååt K, Björkholm M, Xu D. Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene. PLoS One. 2008;3:e1446. [PMID: 18197256 DOI: 10.1371/journal.pone.0001446] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
127 Liu T, Hu B, Chung MJ, Ullenbruch M, Jin H, Phan SH. Telomerase regulation of myofibroblast differentiation. Am J Respir Cell Mol Biol 2006;34:625-33. [PMID: 16424384 DOI: 10.1165/rcmb.2005-0252OC] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
128 Holt SE, Norton JC, Wright WE, Shay JW. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci 1996;18:237-48. [DOI: 10.1007/bf00132889] [Cited by in Crossref: 86] [Article Influence: 3.3] [Reference Citation Analysis]
129 Godínez-Rubí M, Ortuño-Sahagún D. miR-615 Fine-Tunes Growth and Development and Has a Role in Cancer and in Neural Repair. Cells 2020;9:E1566. [PMID: 32605009 DOI: 10.3390/cells9071566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
130 Ahn EH, Yang H, Hsieh CY, Sun W, Chang CC, Schroeder JJ. Evaluation of chemotherapeutic and cancer-protective properties of sphingosine and C2-ceramide in a human breast stem cell derived carcinogenesis model. Int J Oncol 2019;54:655-64. [PMID: 30483770 DOI: 10.3892/ijo.2018.4641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
131 Giri S, Nieber K, Acikgöz A, Pavlica S, Keller M, Bader A. Telomerase activity and hepatic functions of rat embryonic liver progenitor cell in nanoscaffold-coated model bioreactor. Mol Cell Biochem 2010;336:137-49. [DOI: 10.1007/s11010-009-0266-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
132 Yui J, Chiu C, Lansdorp PM. Telomerase Activity in Candidate Stem Cells From Fetal Liver and Adult Bone Marrow. Blood 1998;91:3255-62. [DOI: 10.1182/blood.v91.9.3255] [Cited by in Crossref: 144] [Article Influence: 6.0] [Reference Citation Analysis]
133 Uziel O, Yerushalmi R, Zuriano L, Naser S, Beery E, Nordenberg J, Lubin I, Adel Y, Shepshelovich D, Yavin H, Ben Aharon I, Pery S, Rizel S, Pasmanik-Chor M, Frumkin D, Lahav M. BRCA1/2 mutations perturb telomere biology: characterization of structural and functional abnormalities in vitro and in vivo. Oncotarget 2016;7:2433-54. [PMID: 26515461 DOI: 10.18632/oncotarget.5693] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
134 Majumdar AS, Hughes DE, Lichtsteiner SP, Wang Z, Lebkowski JS, Vasserot AP. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters. Gene Ther. 2001;8:568-578. [PMID: 11319624 DOI: 10.1038/sj.gt.3301421] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 3.8] [Reference Citation Analysis]
135 Pusceddu I, Farrell CL, Di Pierro AM, Jani E, Herrmann W, Herrmann M. The role of telomeres and vitamin D in cellular aging and age-related diseases. Clinical Chemistry and Laboratory Medicine (CCLM) 2015;53. [DOI: 10.1515/cclm-2014-1184] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
136 Cheung AN, Zhang DK, Liu Y, Ngan HY, Shen DH, Tsao SW. Telomerase activity in gestational trophoblastic disease. J Clin Pathol 1999;52:588-92. [PMID: 10645228 DOI: 10.1136/jcp.52.8.588] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.2] [Reference Citation Analysis]
137 Zhang LP, Jiang JK, Tam JW, Zhang Y, Liu XS, Xu XR, Liu BZ, He YJ. Effects of Matrine on proliferation and differentiation in K-562 cells. Leuk Res. 2001;25:793-800. [PMID: 11489473 DOI: 10.1016/s0145-2126(00)00145-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
138 Yui J, Chiu C, Lansdorp PM. Telomerase Activity in Candidate Stem Cells From Fetal Liver and Adult Bone Marrow. Blood 1998;91:3255-62. [DOI: 10.1182/blood.v91.9.3255.3255_3255_3262] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
139 Li K, Zhang J, Ren JJ, Wang Q, Yang KY, Xiong ZJ, Mao YQ, Qi YY, Chen XW, Lan F, Wang XJ, Xiao HY, Lin P, Wei YQ. A novel zinc finger protein Zfp637 behaves as a repressive regulator in myogenic cellular differentiation. J Cell Biochem 2010;110:352-62. [PMID: 20235149 DOI: 10.1002/jcb.22546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
140 Tzukerman M, Shachaf C, Ravel Y, Braunstein I, Cohen-Barak O, Yalon-Hacohen M, Skorecki KL. Identification of a novel transcription factor binding element involved in the regulation by differentiation of the human telomerase (hTERT) promoter. Mol Biol Cell 2000;11:4381-91. [PMID: 11102531 DOI: 10.1091/mbc.11.12.4381] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
141 Herbert BS, Wright AC, Passons CM, Wright WE, Ali IU, Kopelovich L, Shay JW. Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells. J Natl Cancer Inst. 2001;93:39-45. [PMID: 11136840 DOI: 10.1093/jnci/93.1.39] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
142 Zhang L, Li S, Chen L, Li J, Zhang Z, Yang Y, Wang X, Liu J. Cerebellar fastigial nucleus electrical stimulatin protects against cerebral ischemic damage by upregulating telomerase activity. Restor Neurol Neurosci 2019;37:131-41. [PMID: 30988241 DOI: 10.3233/RNN-180876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Yin F, Liu J, Peng X. Effects of triethylene tetraamine on telomerase activity and proliferation in HeLa cells. Cell Biology International 2004;28:287-91. [DOI: 10.1016/j.cellbi.2004.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
144 Yamaguchi Y, Nozawa K, Savoysky E, Hayakawa N, Nimura Y, Yoshida S. Change in Telomerase Activity of Rat Organs during Growth and Aging. Experimental Cell Research 1998;242:120-7. [DOI: 10.1006/excr.1998.4102] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
145 King WA, Coppola G, Alexander B, Mastromonaco G, Perrault S, Nino-Soto MI, Pinton A, Joudrey EM, Betts DH. The impact of chromosomal alteration on embryo development. Theriogenology 2006;65:166-77. [PMID: 16280155 DOI: 10.1016/j.theriogenology.2005.09.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
146 Adler S, Pellizzer C, Paparella M, Hartung T, Bremer S. The effects of solvents on embryonic stem cell differentiation. Toxicology in Vitro 2006;20:265-71. [DOI: 10.1016/j.tiv.2005.06.043] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 4.6] [Reference Citation Analysis]
147 Aldous WK, Grabill NR. A Fluorescent Method for Detection of Telomerase Activity: . Diagnostic Molecular Pathology 1997;6:102-10. [DOI: 10.1097/00019606-199704000-00006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
148 Kim HI, Moon SH, Lee WC, Lee HJ, Shivakumar SB, Lee SH, Park BW, Rho GJ, Jeon BG. Inhibition of cell growth by cellular differentiation into adipocyte-like cells in dexamethasone sensitive cancer cell lines. Anim Cells Syst (Seoul) 2018;22:178-88. [PMID: 30460096 DOI: 10.1080/19768354.2018.1476408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
149 Tollefsbol T, Andrews L. Mechanisms for telomerase gene control in aging cells and tumorigenesis. Medical Hypotheses 2001;56:630-7. [DOI: 10.1054/mehy.2000.1241] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
150 Wen J, Wang L, Zhang M, Xie D, Sun L. Repression of Telomerase Activity During In Vitro Differentiation of Osteosarcoma Cells. Cancer Investigation 2002;20:38-45. [DOI: 10.1081/cnv-120000364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
151 Morrison SJ, Prowse KR, Ho P, Weissman IL. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity. 1996;5:207-216. [PMID: 8808676 DOI: 10.1016/s1074-7613(00)80316-7] [Cited by in Crossref: 282] [Cited by in F6Publishing: 99] [Article Influence: 10.8] [Reference Citation Analysis]
152 Tamura K, Liu H, Takahashi H. Auxin Induction of Cell Cycle Regulated Activity of Tobacco Telomerase. Journal of Biological Chemistry 1999;274:20997-1002. [DOI: 10.1074/jbc.274.30.20997] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
153 Yudoh K, Matsuno H, Nakazawa F, Katayama R, Kimura T. Reconstituting Telomerase Activity Using the Telomerase Catalytic Subunit Prevents the Telomere Shorting and Replicative Senescence in Human Osteoblasts. J Bone Miner Res 2001;16:1453-64. [DOI: 10.1359/jbmr.2001.16.8.1453] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 3.3] [Reference Citation Analysis]
154 Fu W, Begley JG, Killen MW, Mattson MP. Anti-apoptotic role of telomerase in pheochromocytoma cells. J Biol Chem. 1999;274:7264-7271. [PMID: 10066788 DOI: 10.1074/jbc.274.11.7264] [Cited by in Crossref: 168] [Cited by in F6Publishing: 171] [Article Influence: 7.3] [Reference Citation Analysis]
155 Fukutomi M, Enjoji M, Iguchi H, Yokota M, Iwamoto H, Nakamuta M, Sakai H, Nawata H. Telomerase activity is repressed during differentiation along the hepatocytic and biliary epithelial lineages: verification on immortal cell lines from the same origin. Cell Biochem Funct 2001;19:65-8. [PMID: 11223873 DOI: 10.1002/cbf.891] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
156 Yokoyama Y, Takahashi Y, Morishita S, Hashimoto M, Tamaya T. Introduction of p21(Waf1/Cip1) gene into a carcinoma cell line of the uterine cervix with inactivated p53. Cancer Lett 1997;116:233-9. [PMID: 9215868 DOI: 10.1016/s0304-3835(97)00193-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
157 Zeng XL, Tu ZG. In vitro induction of differentiation by ginsenoside Rh2 in SMMC-7721 hepatocarcinoma cell line. Pharmacol Toxicol 2003;93:275-83. [PMID: 14675461 DOI: 10.1111/j.1600-0773.2003.pto930605.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
158 Pillet F, Romera C, Trévisiol E, Bellon S, Teulade-fichou M, François J, Pratviel G, Leberre VA. Surface plasmon resonance imaging (SPRi) as an alternative technique for rapid and quantitative screening of small molecules, useful in drug discovery. Sensors and Actuators B: Chemical 2011;157:304-9. [DOI: 10.1016/j.snb.2011.03.082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
159 Tao L, Zhang W, Zhang Y, Zhang M, Zhang Y, Niu X, Zhao Q, Liu Z, Li Y, Diao A. Caffeine promotes the expression of telomerase reverse transcriptase to regulate cellular senescence and aging. Food Funct 2021;12:2914-24. [PMID: 33720241 DOI: 10.1039/d0fo03246h] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Cheng AJ, Liao SK, Chow SE, Chen JK, Wang TC. Differential inhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma, and glioma cells in culture. Biochem Biophys Res Commun 1997;237:438-44. [PMID: 9268730 DOI: 10.1006/bbrc.1997.7157] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
161 Kleinschmidt-demasters B, Evans LC, Bitter MA, Shroyer A, Shroyer KR. Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis. Journal of the Neurological Sciences 1998;161:124-34. [DOI: 10.1016/s0022-510x(98)00254-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
162 Adler S, Paparella M, Pellizzer C, Hartung T, Bremer S. The Detection of Differentiation-inducing Chemicals by using Green Fluorescent Protein Expression in Genetically Engineered Teratocarcinoma Cells. Altern Lab Anim 2005;33:91-103. [DOI: 10.1177/026119290503300204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
163 Shtessel L, Lowden MR, Cheng C, Simon M, Wang K, Ahmed S. Caenorhabditis elegans POT-1 and POT-2 repress telomere maintenance pathways. G3 (Bethesda) 2013;3:305-13. [PMID: 23390606 DOI: 10.1534/g3.112.004440] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
164 Eitsuka T, Nakagawa K, Kato S, Ito J, Otoki Y, Takasu S, Shimizu N, Takahashi T, Miyazawa T. Modulation of Telomerase Activity in Cancer Cells by Dietary Compounds: A Review. Int J Mol Sci 2018;19:E478. [PMID: 29415465 DOI: 10.3390/ijms19020478] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
165 Mathon NF, Lloyd AC. Cell senescence and cancer. Nat Rev Cancer 2001;1:203-13. [DOI: 10.1038/35106045] [Cited by in Crossref: 183] [Cited by in F6Publishing: 156] [Article Influence: 8.7] [Reference Citation Analysis]
166 Liu BC, Loughlin KR. TELOMERASE IN HUMAN BLADDER CANCER. Urologic Clinics of North America 2000;27:115-23. [DOI: 10.1016/s0094-0143(05)70239-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
167 Nakano K, Watney E, McDougall JK. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am J Pathol. 1998;153:857-864. [PMID: 9736034 DOI: 10.1016/s0002-9440(10)65627-1] [Cited by in Crossref: 70] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
168 Kim JH, Park DC, Kim JW, Choi YK, Lew YO, Kim DH, Jung JK, Lim YA, Namkoong SE. Antitumor Effect of GnRH Agonist in Epithelial Ovarian Cancer. Gynecologic Oncology 1999;74:170-80. [DOI: 10.1006/gyno.1999.5413] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
169 Brousset P, Al Saati T, Chaouche N, Zenou R, Schlaifer D, Chittal S, Delsol G. Telomerase Activity in Reactive and Neoplastic Lymphoid Tissues: Infrequent Detection of Activity in Hodgkin's Disease. Blood 1997;89:26-31. [DOI: 10.1182/blood.v89.1.26] [Cited by in Crossref: 36] [Article Influence: 1.4] [Reference Citation Analysis]
170 Swanberg SE, Payne WS, Hunt HD, Dodgson JB, Delany ME. Telomerase activity and differential expression of telomerase genes and c-myc in chicken cells in vitro. Dev Dyn 2004;231:14-21. [PMID: 15305283 DOI: 10.1002/dvdy.20149] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
171 Liu L, DiGirolamo CM, Navarro PA, Blasco MA, Keefe DL. Telomerase deficiency impairs differentiation of mesenchymal stem cells. Exp Cell Res 2004;294:1-8. [PMID: 14980495 DOI: 10.1016/j.yexcr.2003.10.031] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 5.4] [Reference Citation Analysis]
172 Elwood NJ. Telomere Biology of Human Hematopoietic Stem Cells. Cancer Control 2017;11:77-85. [DOI: 10.1177/107327480401100214] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
173 Erdem E, Dıkmen G, Atsü N, Doğan P, Özen H. Telomerase Activity in Diagnosis of Bladder Cancer*. Scandinavian Journal of Urology and Nephrology 2003;37:205-9. [DOI: 10.1080/00365590310008055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
174 Leung DT, Ma C, Niu H, Liew C, Tang JT, Lim P. Nuclear telomerase is less accessible to antibody probing than known nuclear antigens: retrieval with new immunostaining buffer. Histochem Cell Biol 2005;123:105-12. [DOI: 10.1007/s00418-004-0721-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
175 Reichman TW, Albanell J, Wang X, Moore MA, Studzinski GP. Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J Cell Biochem 1997;67:13-23. [DOI: 10.1002/(sici)1097-4644(19971001)67:1<13::aid-jcb2>3.0.co;2-z] [Cited by in Crossref: 28] [Article Influence: 1.1] [Reference Citation Analysis]
176 Buchkovich KJ, Greider CW. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 1996;7:1443-54. [PMID: 8885238 DOI: 10.1091/mbc.7.9.1443] [Cited by in Crossref: 149] [Cited by in F6Publishing: 152] [Article Influence: 6.0] [Reference Citation Analysis]
177 Seimiya H, Tanji M, Oh-hara T, Tomida A, Naasani I, Tsuruo T. Hypoxia Up-Regulates Telomerase Activity via Mitogen-Activated Protein Kinase Signaling in Human Solid Tumor Cells. Biochemical and Biophysical Research Communications 1999;260:365-70. [DOI: 10.1006/bbrc.1999.0910] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 2.9] [Reference Citation Analysis]
178 Berei J, Eckburg A, Miliavski E, Anderson AD, Miller RJ, Dein J, Giuffre AM, Tang D, Deb S, Racherla KS, Patel M, Vela MS, Puri N. Potential Telomere-Related Pharmacological Targets. CTMC 2020;20:458-84. [DOI: 10.2174/1568026620666200109114339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
179 Haïk S, Gauthier LR, Granotier C, Peyrin JM, Lages CS, Dormont D, Boussin FD. Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells. Oncogene 2000;19:2957-66. [PMID: 10871847 DOI: 10.1038/sj.onc.1203596] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 2.1] [Reference Citation Analysis]
180 Norrback K, Enblad G, Erlanson M, Sundström C, Roos G. Telomerase Activity in Hodgkin's Disease. Blood 1998;92:567-73. [DOI: 10.1182/blood.v92.2.567] [Cited by in Crossref: 32] [Article Influence: 1.3] [Reference Citation Analysis]
181 Gilchrist G, Kurjanowicz P, Mereilles F, King W, Lamarre J. Telomere Length and Telomerase Activity in Bovine Pre-implantation Embryos In Vitro. Reprod Dom Anim 2015;50:58-67. [DOI: 10.1111/rda.12449] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
182 Holt SE, Aisner DL, Shay JW, Wright WE. Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci USA. 1997;94:10687-10692. [PMID: 9380696 DOI: 10.1073/pnas.94.20.10687] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 4.0] [Reference Citation Analysis]
183 Robertson JD, Gale RE, Wynn RF, Dougal M, Linch DC, Testa NG, Chopra R. Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. Br J Haematol 2000;109:272-9. [PMID: 10848812 DOI: 10.1046/j.1365-2141.2000.01970.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 3.2] [Reference Citation Analysis]
184 Ahmed A, Tollefsbol TO. Telomerase, telomerase inhibition, and cancer. J Anti Aging Med 2003;6:315-25. [PMID: 15142433 DOI: 10.1089/109454503323028911] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
185 Fajkus J, Kovařík A, Královics R. Telomerase activity in plant cells. FEBS Letters 1996;391:307-9. [DOI: 10.1016/0014-5793(96)00757-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 1.9] [Reference Citation Analysis]
186 Forsyth NR, Wright WE, Shay JW. Telomerase and differentiation in multicellular organisms: Turn it off, turn it on, and turn it off again. Differentiation 2002;69:188-97. [DOI: 10.1046/j.1432-0436.2002.690412.x] [Cited by in Crossref: 246] [Cited by in F6Publishing: 211] [Article Influence: 12.3] [Reference Citation Analysis]